跳至主要内容
临床试验/NCT06967207
NCT06967207招募中不适用

Electrical Impedance Tomography-Based Prognostic Model for ARDS: A Multicenter, Prospective, Observational Study

XiaoJing Zou,MD4 个研究点 分布在 1 个国家目标入组 625 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
625
试验地点
4
主要终点
28-day mortality rate

研究概览

简要总结

This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the new 2023 ARDS global definition;
  • Age 18-80 years

排除标准

  • Expected death within 24 hours of screening;
  • Metastatic cancer (active malignancy with distant metastases);
  • Severe psychiatric disorders;
  • Pregnancy or postpartum status;
  • Pneumothorax or moderate to large pleural effusion without adequate drainage;
  • Chronic respiratory failure;
  • Patients with pulmonary embolism or pulmonary hypertension;
  • Heart failure patients: EF <50% or NYHA class III or IV;
  • Patient/family refusal to participate;
  • Participation in another interventional trial within 3 months prior to enrollment

结局指标

主要结局

28-day mortality rate

时间窗: From date of study enrollment (Day 0) until Day 28

次要结局

  • ICU mortality rate(From ICU admission to discharge, up to 24 weeks)
  • 60-day all-cause mortality rate(60 days post-enrollment)
  • 90-day all-cause mortality rate(90 days post-enrollment)
  • Duration of mechanical ventilation (days)(From intubation to successful extubation, up to 28 days)
  • Ventilator-free days (VFDs) at 28 days(28 days post-enrollment)
  • ICU length of stay (days)(From ICU admission to discharge, up to 24 weeks)
  • Hospital length of stay(From hospital admission to discharge, up to 24 weeks)

研究者

发起方
XiaoJing Zou,MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

XiaoJing Zou,MD

MD

Wuhan Union Hospital, China

研究点 (4)

Loading locations...

相似试验